United States Parkinson Disease Report 2017: Market Insights, Epidemiology and Market Forecast 2010-2023 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Parkinson Disease - Market Insights, Epidemiology and Market Forecast - 2023 - United States" drug pipelines to their offering.

Parkinson Disease - Market Insights, Epidemiology and Market Forecast - 2023 - United States Reports provides an overview of the disease and global market size of the Parkinson Disease for the United States. It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Parkinson Disease from 2010-2023.

Parkinson's disease (PD) is a disorder caused by the malfunction and death of neurons. It is a chronic and progressive movement disorder which primarily affects neurons in substantia nigra area of the brain. Dopamine is usually responsible for the control and coordination process which is affected when the neuron malfunction and death occurs. As the disease progresses, the amount of dopamine produced in the brain decreases as a result the person is unable to control movement normally. This degenerative disorder affects the central nervous system.

Scope:

  • Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
  • Marketed information including available prescription drugs, its patent and exclusivity details.
  • The report also covers the detailed global historical and forecasted epidemiological data covering United States from 2010-2023.
  • It also provides Market size of Parkinson disease for United States from 2010 and forecasted Market size to 2023.

Key Topics Covered:

  1. Introduction
  2. Parkinson Disease Market Overview at a Glance
  3. Total Market Size of Parkinson Disease for 7 MM in 2013-2023
  4. Total Market Share Distribution of Parkinson Disease for 7 MM in 2015
  5. Total Market Share Distribution of Parkinson Disease for 7 MM in 2023
  6. Parkinson Disease
  7. Overview
  8. Symptoms
  9. Pathophysiology
  10. Staging
  11. Diagnosis
  12. Treatment
  13. Epidemiology and Patient Population
  14. United States
  15. Diagnosed Cases of Parkinson Disease in United States
  16. Marketed Drugs

Top Marketed Drugs for Parkinson disease

  • Azilect: Teva Pharmaceutical Industries
  • Exelon/Exelon Patch: Novartis
  • Stalevo: Orion Corporation
  • Comtan/Comtess: Orion Corporation

Major Pipeline drugs

  • Istradefylline
  • Tozadenant
  • CVT-301

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/gnzkv4/parkinson_disease

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs, Central Nervous System Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs, Central Nervous System Drugs